bioRxiv Science⌕ Search

Biology subjects

Najafi, A.

Publications and source records attributed to Najafi, A..

5 recordsLinked to original sources

Inferring EMT dynamics from cell cycle profiles using a hidden Markov framework

The Epithelial-to-Mesenchymal Transition (EMT) which is a driver of metastasis and a contributor to wound healing, embryogenesis, and trophoblast differentiation is highly context specific, making it difficult to infer robustly from sequencing data. Existing methods often require that epithelial, hybrid, and mesenchymal states all be present in the same dataset and rely on simplifying assumptions that limit generalizability. By contrast, cell cycle stage is routinely and reliably inferred from transcriptomic profiles. We leverage this robustness to recover EMT dynamics when direct EMT inference fails. Specifically, we learn an emission model that links latent EMT states to observed cell cycle stage frequencies using datasets with known EMT trajectories. We then use this model, together with the initial EMT distribution of a cell line, to demonstrate that we can reconstruct EMT trajectories from time-series measurements of cell cycle stage alone. Finally, we provide an open-source R package and a companion web application to make the approach accessible and reproducible. SIGNIFICANCEElucidating EMT dynamics is central to understanding metastasis and therapy response, yet EMT is notoriously context-specific and often cannot be inferred reliably from transcriptomic data alone. We introduce a population-level hidden Markov model that links latent EMT states to observed cell cycle compositions via an estimated emission matrix thereby enabling the reconstruction of EMT trajectories and transition rates using only cell cycle fractions and a baseline EMT distribution (specific to the cell line). This leverages the strong coupling we observe between EMT progression and cell cycle regulation across cell lines, while remaining robust when direct EMT inference fails. We provide an open-source R package and web app to make these analyses accessible.

bioinformatics↗

Identifying Molecular Determinants and Therapeutic Targets in Luminal B Breast Cancer: A Systems Biology Approach

Luminal B breast cancer (LBBC) is on the rise worldwide, with both incidence and mortality rates steadily increasing. Early detection proves difficult due to its aggressive characteristics, most notably its heightened proliferation rate and the complex interplay of molecular biomarkers, particularly in more advanced stages. In the present study, we conducted an in silico analysis of LBBC cell lines using the Gene Expression Omnibus (GEO) microarray dataset, which includes 30 LBBC and 11 normal samples. Differentially expressed genes (DEGs) were identified using RStudio. A series of analyses, including cancer data interrogation via pan-cancer analysis, eXpression2Kinases (X2K), and the Cancer Dependency Map (DepMAP), was carried out to elucidate the underlying signaling pathways, transcription factors (TFs), and kinases, as well as to perform stemformatics analysis. Protein-protein interaction (PPI) networks were reconstructed using STRING and Cytoscape, enabling the identification of co-expressed and hub genes through the cytoHubba plug-in. Of note, FGF2, EGFR, ADIPOQ, LIPE, MET, IGF1, FGF1, EGF, FGF7, and PPARG were identified as the top 10 driver genes; RELA, PPARG, CTCF, EGR1, and NFE2L2 were detected as predominant TFs in LBBC; and CDK1, CDK2, MAPK3, CSNK2A1, and MAPK14 were identified as potential biomarkers through hub gene clustering. Further analysis indicated hsa-mir-221-3p and hsa-mir-29a-3p as key miRNAs targeting LBBC-related genes. Collectively, our findings highlighted LBBC-associated genes, TFs, miRNAs, and pathways as prospective biomarkers, providing insights into LBBC diagnosis and therapeutic approaches.

bioinformatics↗

Distinct Tumor-TAM Interactions in IDH-Stratified Glioma Microenvironments unveiled by Single-Cell and Spatial Transcriptomics

Tumor-associated macrophages (TAMs) residing in the tumor microenvironment (TME) are characterized by their pivotal roles in tumor progression, antitumor immunity, and TME remodeling. However, a thorough comparative characterization of tumor-TAM crosstalk across IDH-defined categories of glioma remains elusive. We delineated the phenotypic heterogeneity of TAMs across IDH-stratified gliomas. Notably, two TAM subsets with a mesenchymal phenotype were enriched in IDH-WT glioblastoma (GBM) and correlated with poorer patient survival and reduced response to anti-PD1 immune checkpoint inhibitor (ICI). We proposed SLAMF9 receptor as a potential therapeutic target. Inference of gene regulatory networks identified PPARG, ELK1, and MXI1 as master transcription factors of mesenchymal BMD-TAMs. Analyses of reciprocal tumor-TAM interactions, revealed distinct crosstalk in IDH-WT tumors, including ANXA1-FPR1/3, FN1-ITGAVB1, VEGFA-NRP1, and TNFSF12-TNFRSF12A. Furthermore, we demonstrated significant upregulation of ANXA1, FN1, NRP1, and TNFRSF12A genes in IDH-WT tumors using bulk RNA-seq and RT-qPCR. Longitudinal expression analysis of candidate genes revealed no difference between primary and recurrent tumors. Collectively, our study offers insights into the unique cellular composition and communication of TAMs in glioma TME, revealing novel vulnerabilities for therapeutic interventions in IDH-WT GBM.

cancer biology↗

Population Dynamics of EMT Elucidates the Timing and Distribution of Phenotypic Intra-tumoral Heterogeneity

The Epithelial-to-Mesenchymal Transition (EMT) is a hallmark of cancer metastasis and morbidity. EMT is a non-binary process, and cells can be stably arrested en route to EMT in an intermediate hybrid state associated with enhanced tumor aggressiveness and worse patient outcomes. Understanding EMT progression in detail will provide fundamental insights into the mechanisms underlying metastasis. Despite increasingly available single-cell RNA sequencing data that enable in-depth analyses of EMT at the single-cell resolution, current inferential approaches are limited to bulk microarray data. There is thus a great need for computational frameworks to systematically infer and predict the timing and distribution of EMT-related states at single-cell resolution. Here, we develop a computational framework for reliable inference and prediction of EMT-related trajectories from single-cell RNA sequencing data. Our model can be utilized across a variety of applications to predict the timing and distribution of EMT from single-cell sequencing data. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=140 SRC="FIGDIR/small/523978v1_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@1c56970org.highwire.dtl.DTLVardef@18d7371org.highwire.dtl.DTLVardef@19612f9org.highwire.dtl.DTLVardef@1b7cf96_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIA fully stochastic model elucidates the population dynamics of EMT C_LIO_LIA data-driven pipeline is introduced to track EMT trajectories from single-cell RNA sequencing C_LIO_LICell cycle scoring reveals cell line-dependent patterns of EMT Induction C_LI

bioengineering↗

Effect of crocin and naringenin supplementation in cryopreservation medium on post-thawed rooster sperm quality and expression of apoptosis associated genes

The aim of our research was to examine the effects of crocin (0.5 (C0.5), 1 (C1) and 1.5 (C1.5) mM) and naringenin (50 (N50), 100 (N100) and 150 (N150) {micro}M) in cryopreservation extender for freezing rooster semen. Sperm motility, viability, abnormalities, membrane integrity, mitochondrial activity, apoptosis status, lipid peroxidation (LP), GPX, SOD, TAC, the mRNA expression of pro-apoptotic (CASPASE 3) and anti-apoptotic (Bcl-2) genes, fertility and hatchability rate were investigated following freeze-thawing. C1 and N100 resulted in the higher (P < 0.05) total motility and progressive motility in comparison to the control group. C1 and N100 improved viability, membrane integrity and reduced lipid peroxidation. We found much higher values for mitochondria activity with C1 and N100 respect to the control group. The C1 and N100 showed lower percentages of early apoptosis when compared with control group. Also, C1 and N100 had higher TAC when compared with control group. The mRNA expression of BCL-2 in the C1 and N100 group were significantly higher than that of other treatments. The expression of CASPASES 3 was significantly reduced in C1 and N100 group (P < 0.05) when compared to control group. Significantly higher percentage of fertility and hatching rate were observed in C1 and N100 compared to the control group. In conclusion, crocin at 1 mM and naringenin at 100 {micro}M seem to improve the post-thawing rooster semen quality, fertility and could protect the sperm against excessive ROS generation by reducing the pro-apoptotic (CASPASE 3) and increasing anti-apoptotic (Bcl-2) genes.

physiology↗